USPTO serial 79368595
POPVAX: POPULATION-SCALE VACCINES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 6, 2025
- Examiner
- FAIRBANKS, RONALD L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with POPVAX: POPULATION-SCALE VACCINES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lauren K. Tagarao
Lauren K. Tagarao Renner, Otto, Boisselle & Sklar, LLP1621 Euclid AvenueFloor 19Cleveland, OH 44115Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medical preparations for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; pharmaceuticals, medical and veterinary preparations for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; biological preparations for medical purposes, for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; biological preparations for veterinary purposes, for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; chemical preparations for medical purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; chemical preparations for pharmaceutical purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; diagnostic preparations for medical purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; drugs for medical purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; medicines for human purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; vaccines for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, and reproductive disorders; medical, biological and pharmaceutical preparations containing nucleic acids or proteins for the prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, and reproductive disorders; a full line of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars and therapeutic for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose. | ACTIVE | — |
| 042 | Biological research; medical research; scientific laboratory services; scientific research; chemical research; research and development of new products for others; technological research; scientific, medical, biological research and development in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars; clinical trials and testing services in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars; engineering services relating to research and development of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; Software as a service (SaaS) services featuring computer software for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers, and formulations, Software as a service (SaaS) services featuring computer software for controlling, optimization, calibration, maintenance, diagnostics, and troubleshooting of bioprocess systems, equipments, tools, and apparatus namely mixing devices, microfluidic devices, micro-mixing devices, mixing vessels, filtration systems, fermenters or bioreactors, liquid handling systems, separation systems, purification systems, chromatography systems, formulation systems, analytical systems, characterization systems, filling system, lyophilisation system, spray drying system, encapsulation system, pumps, pressure vessels, sensors, actuators, flow controllers, control system for fluidics, automated control systems, robotic systems, synthesis systems, and thermocyclers, Software as a service (SaaS) services featuring computer software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of experiments related to molecular biology, cell biology, biochemistry, organic chemistry, inorganic chemistry, biophysics, immunology, sequencing, toxicology, pharmacodynamics, pharmacokinetics, biodistribution, formulation, drug delivery, bioassays, analytical assays, and analytical characterization for production or manufacturing of pharmaceutical and biopharmaceutical preparations, data management, or clinical trial management; creation of websites for others featuring information in the pharmaceutical, medical and health fields; hosting of a website featuring non-downloadable podcasts in pharmaceutical, medical and health fields. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by POPVAX PRIVATE LIMITED
- Other trademarks owned by POPVAX PRIVATE LIMITED
- Other trademarks owned by POPVAX PRIVATE LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named POPVAX: POPULATION-SCALE VACCINES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 11, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 26, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 26, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 6, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 6, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 6, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 18, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 18, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 12, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 4, 2025 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 22, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 29, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 26, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 26, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 19, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 18, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 18, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 18, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 18, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 18, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 2, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 2, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 29, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 29, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 29, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 20, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 20, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 20, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 11, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 20, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 20, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 1, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 31, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 24, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 9, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 5, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 4, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |